HOXA10 and acute myeloid leukemia: In addition, the transcription factor homeobox A10 (HOXA10), a protein related to leukemogenesis and chemoresistance that has been proposed as a prognostic marker for AML patients (Yi et al., 2016; Guo et al., 2020), was also differentially modulated.